| Evaluation of minimal residual disease by real-time quantitative PCR of Wilms’ tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell … M Kwon, C Martínez-Laperche, M Infante, F Carretero, P Balsalobre, ... Biology of Blood and Marrow Transplantation 18 (8), 1235-1242, 2012 | 94 | 2012 |
| Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group S Alonso‐Álvarez, L Magnano, M Alcoceba, M Andrade‐Campos, ... British journal of haematology 178 (5), 699-708, 2017 | 83 | 2017 |
| Molecular alterations in acute myeloid leukemia and their clinical and therapeutical implications MS Infante, MÁ Piris, JÁ Hernández-Rivas Medicina Clínica (English Edition) 151 (9), 362-367, 2018 | 46 | 2018 |
| Treatment with daratumumab in patients with relapsed/refractory AL amyloidosis: a multicentric retrospective study and review of the literature R Lecumberri, I Krsnik, E Askari, M Sirvent, MS González-Pérez, ... Amyloid 27 (3), 163-167, 2020 | 38 | 2020 |
| Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population L Magnano, S Alonso‐Alvarez, M Alcoceba, A Rivas‐Delgado, ... British Journal of Haematology 185 (3), 480-491, 2019 | 36 | 2019 |
| The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona‐Brno Biomarkers … C Muñoz-Novas, M Poza-Santaella, I González-Gascón y Marín, ... BioMed Research International 2018 (1), 9506979, 2018 | 31 | 2018 |
| RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group M Bastos-Oreiro, A Muntanola, C Panizo, E Gonzalez-Barca, ... Annals of Hematology 99, 799-808, 2020 | 30 | 2020 |
| COVID‐19 in patients with hematological malignancies: a retrospective case series MS Infante, IGG y Marín, C Muñoz‐Novas, J Churruca, MÁ Foncillas, ... International journal of laboratory hematology 42 (6), e256, 2020 | 28 | 2020 |
| B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: a European Hematology Association Survey (EPICOVIDEHA) MS Infante, J Salmanton-García, A Fernandez-Cruz, F Marchesi, O Jaksic, ... Frontiers in oncology 12, 992137, 2022 | 13 | 2022 |
| Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET/CT after adenovirus-vectored COVID-19 vaccine E Landete, I Gómez-Fernández, I González-Gascón-y-Marín, ... Human Vaccines & Immunotherapeutics 17 (12), 5129-5132, 2021 | 13 | 2021 |
| High penetrance of inferior vena cava system atresia in severe thrombophilia caused by homozygous antithrombin Budapest 3 variant: Description of a new syndrome ME de la Morena‐Barrio, R Gindele, C Bravo‐Pérez, P Ilonczai, I Zuazu, ... American Journal of Hematology 96 (11), 1363-1373, 2021 | 13 | 2021 |
| Blood transfusion activity in a general hospital during the COVID‐19 pandemic K Marín‐Mori, I González‐Gascón y Marín, MÁ Foncillas‐García, ... Vox sanguinis 116 (5), 574-580, 2021 | 13 | 2021 |
| Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real‐world study M Stefania Infante, A Fernández‐Cruz, L Núñez, C Carpio, ... Cancer Medicine 10 (21), 7629-7640, 2021 | 12 | 2021 |
| Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 J Salmanton-García, F Marchesi, F Farina, B Weinbergerová, F Itri, ... EClinicalMedicine 71, 2024 | 10 | 2024 |
| Outcomes and management of the SARS-CoV2 omicron variant in recipients of hematopoietic cell transplantation and chimeric antigen receptor T cell therapy MS Infante, D Nemirovsky, S Devlin, S DeWolf, R Tamari, PB Dahi, YJ Lee, ... Transplantation and cellular therapy 30 (1), 116. e1-116. e12, 2024 | 10 | 2024 |
| Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the … A Villalba, AP Gonzalez-Rodriguez, J Arzuaga-Mendez, N Puig, M Arnao, ... Leukemia & lymphoma 63 (14), 3438-3447, 2022 | 10 | 2022 |
| Alteraciones moleculares en leucemia mieloide aguda y sus implicaciones clínicas y terapéuticas MS Infante, MÁ Piris, JÁ Hernández-Rivas Medicina Clínica 151 (9), 362-367, 2018 | 9 | 2018 |
| Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia I Gonzalez-Gascon y Marin, M Hernandez-Sanchez, ... Leukemia & lymphoma 59 (3), 633-642, 2018 | 9 | 2018 |
| Rationale and design of RESILIENCE: a prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity A Moreno‐Arciniegas, A García, M Kelm, F D'Amore, MG da Silva, ... European journal of heart failure 26 (10), 2213-2222, 2024 | 4 | 2024 |
| Extranodal natural killer/T‐cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets E Gonzalez Barca, L Tomás‐Roca, A Esteve, M Rodriguez, L Gato, ... American Journal of Hematology 98 (6), E134-E138, 2023 | 4 | 2023 |
José Ángel HernandezUniversidad Complutense. Hospital Infanta LeonorEmail được xác minh tại salud.madrid.org
